Mission
SEE SCHEDULE O
Public Charity
BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA
Based in SHREVEPORT, LA, BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA operates as a Public Charity. The organization reported $25.3M in revenue, $20.6M in expenses, $120.4M in total assets for fiscal year 2025. Imperigo tracks 15 reported grant relationships connected to this organization totaling approximately $787K.
EIN: 581711612
SHREVEPORT, LA
Biomedicine & Bioengineering Research
NTEE: H92
Latest filing: 2025
Total Revenue$25.3M
Total Expenses$20.6M
Total Assets$120.4M
Grant Records15
Funding Total$787K
Filing Years2021–2025
Where $100 goes at Biomedical Research Foundation of Northwest Louisiana
How Biomedical Research Foundation of Northwest Louisiana divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$96
Programs
the work itself
$4
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $96 for programs
$47
Facilities/intertech
$20
Edventures supports STEM (science, technology, engineering, and mathematics) education and technology-based workforce development initiatives through a variety of programs serving student sin northwest louisiana
$20
Omicron technologies solutions was created to create jobs anddisadvantaged business entity opportunities to the northwest louisianaregion
Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
FOR GENERAL SUPPORT; GIVE FOR GOOD GRANT
$68,782
FOR GENERAL SUPPORT; GIVE FOR GOOD GRANT
$39,300
FOR GENERAL SUPPORT; GIVE FOR GOOD GRANT
$62,668
For recipient's exempt purpose
$10,000
FOR GENERAL SUPPORT; GIVE FOR GOOD GRANT; FOR THE CENTER FOR MOLECULAR IMAGING AND THERAPY
$185,166
Showing up to 5 of 15 total records — full history available with membership.
Officers & Directors
FORMER DIRECTOR
Arlena Acree
SECRETARY/TREASURER
Bart Alexander
PROTOTYPING AND EXPERIMENTATION MGR
Bryan Roundtree
EXECUTIVE DIRECTOR
David Schmidt
EXECUTIVE DIRECTOR
David Smith
VP OF FINANCIAL SERVICES
David West
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $25.3M | $20.6M | $120.4M |
| 2024 | $28.3M | $19.6M | $116.1M |
| 2023 | $24.0M | $20.0M | $108.0M |
| 2022 | $18.0M | $20.0M | $99.9M |
| 2021 | $22.4M | $19.6M | $106.3M |
Between 2021 and 2025, reported annual revenue grew from $22.4M to $25.3M (+13%), with total assets most recently reported at $120.4M.
Interactive year-over-year charts and full filing details available with membership.